Clinical trial
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With…
NCT00134511 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134511 |
|---|---|
| Title | Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder |
| Official title | Phase 3 Multi-Center, Open Label, Forced Titration Study To Evaluate The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Combination Administered Orally, Once Daily (Qd) In Patients With Homozygous Familial Hypercholesterolaemia |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Familial |
| Intervention type | Drug |
| Interventions | Torcetrapib/atorvastatin |
| Enrollment | 30 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Aug 24, 2005 |
| Last update posted | Nov 7, 2007 |
| Countries | Canada, South Africa, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: